CA Prop 65
-13- Proposition 65 List of Chemicals
Leuprolide acetate
developmental, female,
74381-53-6
August 26, 1997
male
Levodopa
developmental
59-92-7
January 29, 1999
Levonorgestrel implants
female
797-63-7
May 15, 1998
Lindane and other hexachloro-
cancer
---
October 1, 1989
cyclohexane isomers
Linuron
developmental
330-55-2
March 19, 1999
Lithium carbonate
developmental
554-13-2
January 1, 1991
Lithium citrate
developmental
919-16-4
January 1, 1991
Lorazepam
developmental
846-49-1
July 1, 1990
Lovastatin
developmental
75330-75-5
October 1, 1992
Lynestrenol
cancer
52-76-6
February 27, 2001
Malathion
Malonaldehyde, sodium salt
cancer
cancer
121-75-5
24382-04-5
May 20, 2016
May 3, 2011
Mancozeb
cancer
8018-01-7
January 1, 1990
Maneb
cancer
12427-38-2
January 1, 1990
Marijuana smoke
cancer
---
June 19, 2009
Me-A-alpha-C (2-Amino-3-methyl-
cancer
68006-83-7
January 1, 1990
9H-pyrido[2,3-b]indole)
Mebendazole
developmental
31431-39-7
August 20, 1999
Medroxyprogesterone acetate
cancer
71-58-9
January 1, 1990
Medroxyprogesterone acetate
developmental
71-58-9
April 1, 1990
Megestrol acetate
cancer
595-33-5
March 28, 2014
Megestrol acetate
developmental
595-33-5
January 1, 1991
MeIQ (2-Amino-3,4-dimethyl-
cancer
77094-11-2
October 1, 1994
imidazo[4,5-f]quinoline)
MeIQx (2-Amino-3,8-dimethyl-
cancer
77500-04-0
October 1, 1994
imidazo[4,5-f]quinoxaline)
Melphalan
cancer
148-82-3
February 27, 1987
Melphalan
developmental
148-82-3
July 1, 1990
Menotropins
developmental
9002-68-0
April 1, 1990
Mepanipyrim
cancer
110235-47-7
July 1, 2008
Meprobamate
developmental
57-53-4
January 1, 1992
2-Mercaptobenzothiazole
Mercaptopurine
cancer
developmental
149-30-4
6112-76-1
October 27, 2017
July 1, 1990
Mercury and mercury compounds
developmental
---
July 1, 1990
Merphalan
cancer
531-76-0
April 1, 1988
Mestranol
cancer
72-33-3
April 1, 1988
Metam potassium
cancer
137-41-7
December 31, 2010
Methacycline hydrochloride
developmental
3963-95-9
January 1, 1991
Metham sodium
cancer
137-42-8
November 6, 1998
Metham sodium
developmental
137-42-8
May 15, 1998
Methanol
developmental
67-56-1
March 16, 2012
Methazole
developmental
20354-26-1
December 1, 1999
Methimazole
developmental
60-56-0
July 1, 1990
Methotrexate
developmental
59-05-2
January 1, 1989
Methotrexate sodium
developmental
15475-56-6
April 1, 1990
5-Methoxypsoralen with
cancer
484-20-8
October 1, 1988
ultraviolet A therapy
8-Methoxypsoralen with
cancer
298-81-7
February 27, 1987
ultraviolet A therapy
2-Methylaziridine (Propyleneimine)
cancer
75-55-8
January 1, 1988
Methylazoxymethanol
cancer
590-96-5
April 1, 1988
Methylazoxymethanol acetate
cancer
592-62-1
April 1, 1988
Methyl bromide, as a structural
developmental
74-83-9
January 1, 1993